Exercise order may boost strength in COPD rehab
NCT ID NCT07655011
First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 2 times
Summary
This trial investigates whether the sequence of endurance and strength exercises during pulmonary rehabilitation affects muscle strength in people with moderate to severe COPD. Participants are randomly assigned to do either strength training before endurance work or the reverse. The study aims to find the best way to structure rehab sessions to improve lower limb strength and overall function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pulmonary rehabilitation with varied exercise order
- What this could lead to
- If one order proves better, it could help optimize rehab programs for COPD patients, potentially improving muscle strength and daily function.
- What could go wrong
- This is a moderate-sized trial testing a subtle change in exercise sequence. The effect may be small or not clinically meaningful, and results may not apply to all COPD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 138 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * COPD GOLD stages 2 to 4 * Admitted for pulmonary rehabilitation in a participating center * Ability to read and speak French * Written informed consent * Affiliation with a social security system Exclusion Criteria: * Legal protection (guardianship or trusteeship) * Pregnancy beyond the second trimester * Musculoskeletal disorders affecting lower limb strength or walking performance * Vascular disease limiting walking distance * Cardiac contraindication to pulmonary rehabilitation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Chu Reims
RECRUITINGReims, 51092, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- COPD may affect the brain and muscles, not just the lungs
- New drug RO7830698 put to the test for COPD
- Can rain sounds make breathing exercises work better for COPD?
- Is RSV a hidden driver of severe COPD attacks?
- Switching to a nebulizer may help COPD patients who get no relief from inhalers
- Can a Pharmacist's talk help COPD patients breathe easier and spend less?